title: How are European patients at risk of malignant arrhythmias or sudden cardiac death identified and informed about their risk profile: results of the European Heart Rhythm Association survey.
abstract: The purpose of this EP wire is to examine clinical practice in the field of screening of patients of risk of ventricular arrhythmias and/or sudden cardiac death (SCD) in European countries. A systematic screening programme existed in the majority of centres and was organized by a multidisciplinary dedicated team or by an activity programme of implantable cardioverter-defibrillator (ICD) or heart failure clinics. In particular, high-risk subgroups of patients with ischaemic and non-ischaemic cardiomyopathy ICD implantation are considered strongly indicated within 90 days of myocardial revascularization or initial diagnosis. Cardiac magnetic resonance imaging appears as an important tool to better characterize the left ventricular arrhythmogenic substrate in patients at risk of SCD.
authors.affiliation: Cardiology Unit, University Hospital S. Maria Della Misericordia, Udine, Italy proclemer.alessandro@aoud.sanita.fvg.it.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Proclemer
authors.affiliation: Second Cardiology Department, University Hospital of Pisa, Pisa, Italy.
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Bongiorni
authors.affiliation: Second Cardiology Department, Attikon University Hospital, University of Athens, Athens, Greece.
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Dagres
authors.affiliation: Department of Cardiology, Institution of Medical Science, Uppsala University, Uppsala, Sweden.
authors.forename: Elena
authors.initials: E
authors.lastname: Sciaraffia
authors.affiliation: Liverpool Heart and Chest Hospital, Liverpool, UK.
authors.forename: Derick
authors.initials: D
authors.lastname: Todd
authors.forename: Carina
authors.initials: C
authors.lastname: Blomstrom-Lundqvist
mesh_terms: D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000517:prevention & control*; D009202:Cardiomyopathies / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D016757:Death, Sudden, Cardiac / Q000209:etiology / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D030881:Disclosure / Q000706:statistics & numerical data; D005060:Europe; D006333:Heart Failure / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D006352:Heart Ventricles / Q000473:pathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008403:Mass Screening / Q000379:methods; D017202:Myocardial Ischemia / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D009204:Myocardial Revascularization; D010353:Patient Education as Topic / Q000706:statistics & numerical data; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D018570:Risk Assessment; D011795:Surveys and Questionnaires; D017180:Tachycardia, Ventricular / Q000209:etiology / Q000517:prevention & control; D014693:Ventricular Fibrillation / Q000209:etiology / Q000517:prevention & control
keywords: EHRA survey; EP Wire; Malignant tachyarrhythmias; Risk stratification; Sudden cardiac death